Suchergebnisse - %22Clinical Trial%2C Phase III%22

PubPharm (57)

1

Phase 1b study of pan-AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA/AKT/PTEN-mutated advanced solid tumors

enthalten in: Cancer | 2023

von Pant, S. | Hamilton, E. | Ulahannan, S. | +4

2

Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer

enthalten in: The New England journal of medicine | 2023

von Turner, N. | Oliveira, M. | Howell, S. | +121

3

VERONICA : Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Results

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Lindeman, G. | Fernando, T. | Bowen, R. | +14

4

A phase III trial of alpelisib + trastuzumab ± fulvestrant versus trastuzumab + chemotherapy in HER2+ PIK3CA-mutated breast cancer

enthalten in: Future oncology (London, England) | 2022

von Pérez-Fidalgo, J. | Criscitiello, C. | Carrasco, E. | +5

5

CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer : A Phase I First-in-Humans Study of 89Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2022

von Farwell, M. | Gamache, R. | Babazada, H. | +12

6

Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma : Results from a Proof-of-Concept, Phase Ib Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Abdul Razak, A. | Bauer, S. | Suarez, C. | +14

7

Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early-Stage Breast Cancer

enthalten in: Clinical pharmacology and therapeutics | 2021

von Cairns, J. | Kalari, K. | Ingle, J. | +10

8

Potential for Long-Term Disease Control with Alpelisib Plus Fulvestrant Spans Patient Subgroups in HR+ PIK3CA-Mutated Advanced Breast Cancer

enthalten in: The oncologist | 2021

9

Distinct Gene Expression Signatures Characterize Strong Clinical Responders Versus Nonresponders to Canakinumab in Children With Systemic Juvenile Idiopathic Arthritis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2021

von Verweyen, E. | Pickering, A. | Grom, A. | +1

10

Alpelisib in combination with everolimus ± exemestane in solid tumours : Phase Ib randomised, open-label, multicentre study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Curigliano, G. | Martin, M. | Jhaveri, K. | +11

1
2
3
4
5
6
Nächster »
[6]